← Open Payments lookup

ELIEZER PORTNOY: Open Payments

NPI 1891140083 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,309 in 72 payments from 24 companies in 2025. Trend: 2023 $344 · 2024 $755 · 2025 $1,309

Food & beverage: $1,210Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.10$222
E.R. Squibb & Sons, L.L.C.10$161
AstraZeneca Pharmaceuticals LP10$160
Novartis Pharmaceuticals Corporation6$100
Celgene Corporation5$85
Bayer Healthcare Pharmaceuticals Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.3$57
PFIZER INC.3$53
Astellas Pharma US Inc2$42
TAIHO ONCOLOGY, INC.2$42

Products named: OPDIVO, RYBREVANT, LYNPARZA, REBLOZYL, Enhertu, KISQALI, Nubeqa, ERLEADA.

Industry payments across NY — which companies pay providers there.